Evelyn Partners Investment Management (Europe)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.38M Sell
17,907
-225
-1% -$52.4K 1.51% 18
2025
Q4
$3.75M Sell
18,132
-615
-3% -$122K 1.22% 22
2025
Q3
$3.48M Sell
18,747
-148
-0.8% -$25.4K 1.2% 21
2025
Q2
$2.89M Sell
18,895
-1,332
-7% -$205K 1.04% 29
2025
Q1
$3.35M Sell
20,227
-2,989
-13% -$468K 1.26% 24
2024
Q4
$3.36M Buy
+23,216
New +$3.6M 1.22% 22

Other funds holding JNJ

Evelyn Partners Investment Management (Europe)'s JNJ Position: Q1 2026 in Review

Evelyn Partners Investment Management (Europe) reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q1 2026, selling an estimated $52.4K and leaving 17,907 shares worth $4.38M. The position accounts for 1.51% of the portfolio, ranked #18.

Evelyn Partners Investment Management (Europe) first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,632 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Evelyn Partners Investment Management (Europe) held 17,907 shares of Johnson & Johnson worth $4.38M as of Q1 2026.
  • Evelyn Partners Investment Management (Europe) sold 225 Johnson & Johnson shares in Q1 2026, an estimated $52.4K.
  • Johnson & Johnson made up 1.51% of Evelyn Partners Investment Management (Europe)'s portfolio in Q1 2026, its #18 holding.
  • Evelyn Partners Investment Management (Europe) first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,632 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Evelyn Partners Investment Management (Europe)'s 13F filing for Q1 2026, filed 15 May 2026.